b. pharmaconsult ApS: Financial statements 2020
CVR: 38310232
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
b. pharmaconsult ApS (CVR 38310232) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 2,108,904 and a net result of DKK 146,360 compared with DKK -8,772 the year before. That is a decrease of 14.7% compared with the year before. The profit margin was 6.9%. Equity in the 2020 report amounted to DKK 410,011. The solvency ratio was 76.5%. The company had 2 employees in the financial year.
- Revenue
- DKK 2,108,904
- Gross Profit
- DKK 1,612,000
- Profit/Loss
- DKK 146,360
- Equity
- DKK 410,011
- Total Assets
- DKK 536,024
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 2.1M | 1.6M | 146K | 410K | 2 |
| 2019 | 2.5M | 1.7M | -9K | 318K | 2 |
Official annual report
How creditworthy is b. pharmaconsult ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout b. pharmaconsult ApS
b. pharmaconsult ApS was a Danish company of the type Anpartsselskab based in Gentofte, founded in 2017. The company has been dissolved on 1 March 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named b. pharmaconsult IVS. The company has 1 employee (2020). In 2021, the company reported a gross profit of DKK -73,270 and a net result of DKK -308,775 compared with DKK 146,360 the year before. Equity in the 2021 report amounted to DKK 45,936.